The message is ready to be sent with the following file or link
attachments:

Israel-U.S. cooperation to develop bandage which heals wounds and
regenerates tissue

Oct. 12 -   Israeli start-up Hapto-Biotech and New York-based Ortec
International Inc., have joined forces to develop a bandage capable of
healing wounds and regenerating tissue, using a unique combination of
peptides and collagen. The new technology could also have an important
impact on orthopedic and dental procedures, as well as for the cosmetics
industry. The active peptides were developed by Hapto, a start-up
company established by Hadasit Medical Research and Development Ltd.,
the commercial subsidiary of the Hadassah Medical Organization; the
collagen-based biomaterial was developed by Ortec. The Hapto-Ortec
collaboration is the second stage of a joint research project the two
companies began in 2002, the results of which produced the potential for
the biotech bandage. "This joint venture is an important landmark in our
company's development plan," said Ira Weinstein, Hapto-Biotech CEO. "I
am confident that during the next 24 months, we will make significant
progress in the development of the biotech bandage, which will move us
even further ahead," he said, anticipating positive results from
clinical trials on humans. Haptide TM., Hapto's core technology,
utilizes proprietary synthetic peptides that mimic the mechanism of cell
attachment to fibrin. It was developed by Dr. Raphael Gorodesky of
Hadassah and Dr. Gerard Marx of Hapto.

Shortcut to:
http://www.israel21c.com/bin/en.jsp?enPage=BlankPage&enDisplay=view&enDi
spWhat=Zone&enDispWho=InThePress&enZone=InThePress&Date=10/12/04%2011:14
%20PM#1893


Note: To protect against computer viruses, e-mail programs may prevent
sending or receiving certain types of file attachments.  Check your
e-mail security settings to determine how attachments are handled.